transient receptor potential cation channel, subfamily C, member 1
RGD ID:
619783
Description:
Predicted to enable several functions, including ATPase binding activity; inositol 1,4,5 trisphosphate binding activity; and store-operated calcium channel activity. Involved in cellular response to hypoxia. Predicted to be located in basolateral plasma membrane; membrane raft; and myofibril. Predicted to be part of cation channel complex and receptor complex. Predicted to be active in plasma membrane. Biomarker of type 2 diabetes mellitus. Orthologous to human TRPC1 (transient receptor potential cation channel subfamily C member 1); PARTICIPATES IN calcium/calcium-mediated signaling pathway; glutamate signaling pathway; INTERACTS WITH 2,2',4,4'-Tetrabromodiphenyl ether; 2,3,7,8-tetrachlorodibenzodioxine; 4,4'-sulfonyldiphenol.
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of TRPC1 mRNA
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of TRPC1 mRNA
Chloroquine inhibits the reaction [Oxygen deficiency results in increased expression of TRPC1 mRNA], Chloroquine inhibits the reaction [Oxygen deficiency results in increased expression of TRPC1 protein]
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of TRPC1 mRNA
Chloroquine inhibits the reaction [Oxygen deficiency results in increased expression of TRPC1 mRNA], Chloroquine inhibits the reaction [Oxygen deficiency results in increased expression of TRPC1 protein]
fasudil inhibits the reaction [Oxygen deficiency results in increased expression of TRPC1 protein], Y 27632 inhibits the reaction [Oxygen deficiency results in increased expression of TRPC1 protein]
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of TRPC1 mRNA
Attenuation of store-operated Ca2+ entry and enhanced expression of TRPC channels in caudal artery smooth muscle from Type 2 diabetic Goto-Kakizaki rats.